Basic & Clinical Medicine ›› 2023, Vol. 43 ›› Issue (9): 1472-1476.doi: 10.16352/j.issn.1001-6325.2023.09.1472
• Mini Reviews • Previous Articles Next Articles
FANG Lu1, LIU Ruiqi2, LIANG Peng1, CEN Ying2*
Received:
2022-09-05
Revised:
2023-02-27
Online:
2023-09-05
Published:
2023-09-01
Contact:
*cenying—pls@foxmail.com
CLC Number:
FANG Lu, LIU Ruiqi, LIANG Peng, CEN Ying. Progress on the role of exosomal miRNAs in organ fibrosis[J]. Basic & Clinical Medicine, 2023, 43(9): 1472-1476.
[1] | Kalluri R, Lebleu VS. The biology, function, and biomedical applications of exosomes[J]. Science, 2020, 367.doi: 10.1126/science.aau6977. |
[2] | Chen L, Chen R, Kemper S, et al. Suppression of fibrogenic signaling in hepatic stellate cells by Twist1-dependent microRNA-214 expression: role of exosomes in horizontal transfer of Twist1[J]. Am J Physiol Gastrointest Liver Physiol, 2015, 309: G491-499. |
[3] | Chen J, Yu Y, Li S, et al. MicroRNA-30a ameliorates hepatic fibrosis by inhibiting Beclin1-mediated autophagy[J]. J Cell Mol Med, 2017, 21: 3679-3692. |
[4] | Qu Y, Zhang Q, Cai X, et al. Exosomes derived from miR-181-5p-modified adipose-derived mesenchymal stem cells prevent liver fibrosis via autophagy activation[J]. J Cell Mol Med, 2017, 21: 2491-2502. |
[5] | Sun C, Shi C, Duan X, et al. Exosomal microRNA-618 derived from mesenchymal stem cells attenuate the progression of hepatic fibrosis by targeting Smad4[J]. Bioengineered, 2022, 13: 5915-5927. |
[6] | Chen L, Huang Y, Duan Z, et al. Exosomal miR-500 derived from lipopolysaccharide-treated macrophage accele-rates liver fibrosis by suppressing MFN2[J]. Front Cell Dev Biol, 2021, 9. doi: 10.3389/fcell.2021.716209.eCollection2021. |
[7] | Zhao S, Li W, Yu W, et al. Exosomal miR-21 from tubular cells contributes to renal fibrosis by activating fibroblasts via targeting PTEN in obstructed kidneys[J]. Theranostics, 2021, 11: 8660-8673. |
[8] | Jin J, Qian F, Zheng D, et al. Mesenchymal stem cells attenuate renal fibrosis via exosomes-mediated delivery of microRNA Let-7i-5p antagomir[J]. Int J Nanomedicine, 2021, 16:3565-3578. |
[9] | Li D, Qu J, Yuan X, et al. Mesenchymal stem cells alleviate renal fibrosis and inhibit autophagy via exosome transfer of miRNA-122a[J]. Stem Cells Int, 2022, 2022(1981798). doi: 10.1155/2022/1981798.eCollection2022. |
[10] | Liang M, Zhang D, Zheng D, et al. Exosomes from miR-374a-5p-modified mesenchymal stem cells inhibit the progression of renal fibrosis by regulating MAPK6/MK5/YAP axis[J]. Bioengineered, 2022, 13: 4517-4527. |
[11] | Pan J, Alimujiang M, Chen Q, et al. Exosomes derived from miR-146a-modified adipose-derived stem cells attenuate acute myocardial infarction-induced myocardial damage via downregulation of early growth response factor 1[J]. J Cell Biochem, 2019, 120: 4433-4443. |
[12] | Ke X, Yang R, Wu F, et al. Exosomal miR-218-5p/miR-363-3p from endothelial progenitor cells ameliorate myocardial infarction by targeting the p53/JMY signaling pathway[J]. Oxid Med Cell Longev, 2021, 2021(5529430). doi: 10.1155/2021/5529430.eCollection2021. |
[13] | Wang L, Liu J, Xu B, et al. Reduced exosome miR-425 and miR-744 in the plasma represents the progression of fibrosis and heart failure[J]. The Kaohsiung Journal of Medical Sciences, 2018, 34: 626-633. |
[14] | Xu H, Ling M, Xue J, et al. Exosomal microRNA-21 derived from bronchial epithelial cells is involved in aberrant epithelium-fibroblast cross-talk in COPD induced by cigarette smoking[J]. Theranostics, 2018, 8: 5419-5433. |
[15] | Wang YC, Xie H, Zhang YC, et al. Exosomal miR-107 antagonizes profibrotic phenotypes of pericytes by targeting a pathway involving HIF-1alpha/Notch1/PDGFRbeta/YAP1/Twist1 axis in vitro[J]. Am J Physiol Heart Circ Physiol, 2021, 320: H520-H534. |
[16] | Guiot J, Cambier M, Boeckx A, et al. Macrophage-derived exosomes attenuate fibrosis in airway epithelial cells through delivery of antifibrotic miR-142-3p[J]. Thorax, 2020, 75: 870-881. |
[17] | Yao MY, Zhang WH, Ma WT, et al. MicroRNA-328 in exosomes derived from M2 macrophages exerts a promotive effect on the progression of pulmonary fibrosis via FAM13A in a rat model[J]. Exp Mol Med, 2019, 51: 63.doi: 10.1038/s12276-019-0255-x. |
[18] | Kadota T, Yoshioka Y, Fujita Y, et al. Extracellular vesicles from fibroblasts induce epithelial-cell senescence in pulmonary fibrosis[J]. Am J Respir Cell Mol Biol, 2020, 63: 623-636. |
[19] | Li Y, Zhang J, Shi J, et al. Exosomes derived from human adipose mesenchymal stem cells attenuate hypertrophic scar fibrosis by miR-192-5p/IL-17RA/Smad axis[J]. Stem Cell Res Ther, 2021, 12: 221. doi: 10.1186/s13287-021-02290-0. |
[20] | Li Q, Fang L, Chen J, et al. Exosomal microRNA-21 promotes keloid fibroblast proliferation and collagen production by inhibiting smad7[J]. J Burn Care Res, 2021, 42: 1266-1274. |
[21] | Wang Q, Wang H, Jing Q, et al. Regulation of pancreatic fibrosis by acinar cell-derived exosomal miR-130a-3p via targeting of stellate cell PPAR-gamma[J]. J Inflamm Res, 2021, 14:461-477. |
[22] | Zhang Y, Chang X, Wu D, et al. Down-regulation of exosomal miR-214-3p targeting CCN2 contributes to endometriosis fibrosis and the role of exosomes in the horizontal transfer of miR-214-3p[J]. Reprod Sci, 2021, 28: 715-727. |
[23] | Xiao B, Zhu Y, Huang J, et al. Exosomal transfer of bone marrow mesenchymal stem cell-derived miR-340 attenuates endometrial fibrosis[J]. Biol Open, 2019, 8. doi: 10.1242/bio.039958. |
[24] | Li D, Zhang J, Liu Z, et al. Human umbilical cord mesenchymal stem cell-derived exosomal miR-27b attenuates subretinal fibrosis via suppressing epithelial-mesenchymal transition by targeting HOXC6[J]. Stem Cell Res Ther, 2021, 12: 24. doi: 10.1186/s13287-020-02064-0. |
[25] | Shen T, Zheng Q, Luo H, et al. Exosomal miR-19a from adipose-derived stem cells suppresses differentiation of corneal keratocytes into myofibroblasts[J]. Aging (Albany NY), 2020, 12: 4093-4110. |
[1] | YU Manshu, ZHAO Xiaomin, QIU Mingyue, LIU Chunran, NA Risu. Advances in the treatment of dental stem cells for Parkinson′s disease [J]. Basic & Clinical Medicine, 2024, 44(9): 1298-1302. |
[2] | ZHAO Junli, ZHU Junjun, ZHAN Qiunan, LIU Miao. Bone marrow mesenchymal stem cell-derived exosome inhibits high glucose-induced EMT of peritoneal mesothelial cells [J]. Basic & Clinical Medicine, 2024, 44(8): 1149-1156. |
[3] | GAO Lu, CAI Menghua, XU Yi, HE Wei, CHEN Hui, ZHANG Jianmin. Purification and in vitro functional validation of exosomes from 293T cells with over-expressed membrane-localized IL-3 [J]. Basic & Clinical Medicine, 2024, 44(7): 947-953. |
[4] | YAN Chenhong, JIN Er. Progress of exosomal PD-L1 in diagnosis and treatment of non-small cell lung cancer [J]. Basic & Clinical Medicine, 2023, 43(9): 1457-1461. |
[5] | YANG Yaqian, PAN Yanfang, QU Mengyang, FANG Yan, YING Xiaoping, ZHANG Meiqian, WEI Jing. Progress of research on the role of exosomes in the occurrence and development of liver precancerous lesions [J]. Basic & Clinical Medicine, 2023, 43(9): 1453-1456. |
[6] | CHEN Xingxing, SAI Yipa, HU Xiaoxia, WANG Sanping, LUO Xuan, LIU Jing. Neuroprotective effects of exosomes derived from human umbilical cord mesenchymal stem cells in cerebral palsy mice [J]. Basic & Clinical Medicine, 2023, 43(8): 1201-1207. |
[7] | YAN Lin, LU Juexiu, LUO Ying, LIU Xianxia. Protective effect of BM-MSCs-derived exosome-mediated ferroptosis against anoxia-reoxygenation injury in rat cardiomyoblastl cell line H9c2 [J]. Basic & Clinical Medicine, 2023, 43(5): 771-776. |
[8] | CUI Shiyu, ZHANG Haifeng. Progress in the exosomes mediating SARS-CoV-2 infection and transmission [J]. Basic & Clinical Medicine, 2023, 43(4): 680-684. |
[9] | XU Qian, DUAN Hua, GAN Lu, LIU Qiwei. Research progress of RhoGTPase activating protein in epithelial-mesenchymal transition [J]. Basic & Clinical Medicine, 2023, 43(2): 301-305. |
[10] | YAO Liuxu, LI Yuhong, JIANG Zongming. Research progress of exosome lncRNA in liquid biopsy of colorectal cancer [J]. Basic & Clinical Medicine, 2023, 43(2): 317-321. |
[11] | JIANG Yu, QIAN Haiyan. Progress in application of mesenchymal stem cells in treatment of acute myocardial infarction [J]. Basic & Clinical Medicine, 2023, 43(1): 21-29. |
[12] | SHANG Lipeng, LIU Guoxiang, DING Xiaoyan, LI Bing, ZHAO Chunhua, LI Xiaoxia. Research advances in application of mesenchymal stem cells for aging related diseases [J]. Basic & Clinical Medicine, 2023, 43(1): 38-45. |
[13] | CHEN Lili,SUN Yonghong,LEI Xiaoyan,WANG Jianjun,CHEN Xingxing,BAO Baixin. Research advances in the treatment of lung diseases based on mesenchymal stem cell exosomes [J]. Basic & Clinical Medicine, 2023, 43(1): 192-195. |
[14] | LI Ying-jie, YANG Ting-kai, JI Zhi-gang, WEN Jin. Progress of exosomes in diagnosis and treatment of prostate cancer [J]. Basic & Clinical Medicine, 2022, 42(1): 163-167. |
[15] | YANG Xu-dong, YU Hong-liang, LI Jing, ZHAO Chun-hua. Macrophage J774A.1 exosome promotes the proliferation and migration of colorectal cancer cell lines MC38 and CT26 [J]. Basic & Clinical Medicine, 2021, 41(6): 799-804. |
Viewed | ||||||||||||||||||||||||||||||||||||||||||||||||||
Full text 102
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||
Abstract 123
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||